Association of Biotechnology Led Enterprises

News

Novavax initiates phase 1/2 clinical trial of COVID-19 vaccine

Novavax has identified NVXCoV2373 as its lead SARS-CoV-2 candidate following pre-clinical testing that demonstrated high immunogenicity and high levels of neutralizing antibodies.

May 26, 2020

By : Team ABLE

Sanofi to sell equity investment in Regeneron; confirms no change to ongoing collaboration

Sanofi has announced its intent to sell its equity investment in Regeneron through a registered public offering and related share repurchase by Regeneron.

May 26, 2020

By : Team ABLE

Nominations for BIRAC-SoCH Innovation Challenge Award to close on June 15, 2020

BIRAC’s SoCH Award is aimed at rewarding innovative clean cooking solutions.

May 25, 2020

By : Team ABLE

CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China

It is claimed to be the first novel coronavirus vaccine for COVID-19 that made to this stage in China.

May 25, 2020

By : Team ABLE

Sinovac secures $15 million in funding to accelerate COVID-19 vaccine development

Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development to further the development of an inactivated vaccine against COVID-19 named CoronaVac.

May 25, 2020

By : Team ABLE